GSK Lobs False Ad Suit At Teva Over Axed Wellbutrin Generic
GlaxoSmithKline LLC on Friday launched a false advertising suit in Pennsylvania federal court accusing Teva Pharmaceuticals USA Inc. of costing it hundreds of millions of dollars by promoting a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article